Status:
RECRUITING
ALS Research Collaborative
Lead Sponsor:
ALS Therapy Development Institute
Conditions:
Amyotrophic Lateral Sclerosis
ALS (Amyotrophic Lateral Sclerosis)
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this natural history study is to learn more about the biological and clinical aspects of amyotrophic lateral sclerosis (ALS). This study's findings will help with drug discovery, biomarker...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Can communicate in written English
- Has a diagnosis of ALS/MND or is a known carrier of an ALS associated mutation
Exclusion
- Significant cognitive impairment that would prevent individual completion and understanding of the informed consent process.
Key Trial Info
Start Date :
September 12 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2035
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06885918
Start Date
September 12 2014
End Date
January 31 2035
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ALS Therapy Development Institute
Watertown, Massachusetts, United States, 02472